(Q42265870)

19 October 2017

Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers (English)

1 reference

19 October 2017

Cadigan PJ

1

1 reference

19 October 2017

London DR

2

1 reference

19 October 2017

Pentecost BL

3

1 reference

19 October 2017

Bianchetti G

4

1 reference

19 October 2017

Gomeni R

5

1 reference

19 October 2017

Kilborn JR

6

1 reference

19 October 2017

Morselli PL

7

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 June 1980

1 reference

British Journal of Clinical Pharmacology

19 October 2017

1 reference

19 October 2017

9

1 reference

19 October 2017

6

1 reference

19 October 2017

569-575

1 reference

Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Pharmacokinetics, pharmacology of atenolol and effect of renal disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Clinical Pharmacokinetics of Propranolol

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings]

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Onset and duration of beta-adrenergic receptor blockade following single oral dose acebutolol hydrochloride (Sectral)

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Absorption of the β-Adrenergic-Blocking Agent, Nadolol, by Mice, Rats, Hamsters, Rabbits, Dogs, Monkeys, and Man: An Unusual Species Difference

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430003

The assessment of β-adrenoceptor blocking drugs in hyperthyroidism

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1980.TB01082.X

Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1980.TB01082.X

Metabolic studies on oxprenolol in animals and man by means of radio-tracer techniques and GLC-analysis

21 January 2018

1 reference

12 December 2020

Combined pharmacokinetic and pharmacodynamic studies in man of the adrenergic β1-receptor antagonist metoprolol *

1 reference

12 December 2020

Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration

1 reference

12 December 2020

Clinical pharmacokinetics of atenolol

1 reference

12 December 2020

Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cycloporpylmethoxytheyl)-1-phenoxy-3-isopropyl- aminograpan-2-ol], a new β1 adrenoceptor blocking agent

1 reference

12 December 2020

10.1111/J.1365-2125.1980.TB01082.X

Identifiers

DOI

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

6104498

1 reference